Governing Global Pharmaceutical Dependencies
A framework for exposure, trusted cooperation and responsible de-risking.
Executive argument
Dependence becomes a security problem when it is opaque, concentrated, difficult to substitute and exposed to correlated shocks.
Assessing exposure
Assessment should cover ingredients, materials, packaging, equipment, data services and logistics, combining concentration, criticality, substitutability and recovery time.
Cooperative resilience
Trusted-country agreements, regulatory reliance, shared surveillance and coordinated reserves can reduce risk more efficiently than indiscriminate reshoring.
Conclusion
The aim is not autarky but sufficient diversity, visibility and collective capacity to withstand disruption.
Medicines Security Institute (2026), Governing Global Pharmaceutical Dependencies, MSI Strategic Papers, Paper 04.
Research and correction standard